EQS-News: Abivax secures up to EUR 150M from two structured debt financing transactions
The subsequent tranches of the Kreos / Claret Financing and the Heights Financing are subject to certain conditions, as further set forth below.
- The subsequent tranches of the Kreos / Claret Financing and the Heights Financing are subject to certain conditions, as further set forth below.
- The Kreos / Claret Financing consists of three tranches of EUR 25,000,000 each in aggregate principal amount.
- The convertible bonds, the non-convertible bonds and the warrants of the Kreos / Claret Financing will not be listed on any market.
- Abivax is allowed to pre-pay the amounts due under the second and third tranches of the Kreos / Claret Financing any time.